loading

Sutro Biopharma Inc Azioni (STRO) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
266.37%
63.74
17.40 14.81 8.52 25.71
Operating Expenses
21.91%
67.09
85.91 80.07 76.44 74.39
Benefits Costs and Expenses
19.39%
75.26
93.37 84.90 57.31 73.72
Costs And Expenses
19.39%
75.26
93.37 84.90 57.31 73.72
Operating Income/Loss
95.12%
-3.345
-68.51 -65.26 -67.92 -48.69
Income/Loss From Continuing Operations Before Tax
84.84%
-11.52
-75.97 -70.09 -48.79 -48.01
Income Tax Expense/Benefit
357.14%
-0.018
0.007 2.355 - 0.008
Income/Loss From Continuing Operations After Tax
84.86%
-11.50
-75.97 -72.44 -48.79 -48.02
Net Income/Loss
84.86%
-11.50
-75.97 -72.44 -48.79 -48.02
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1.77%
84.58
83.11 1.8945 82.04 81.22
Diluted Average Shares
1.77%
84.58
83.11 1.8945 82.04 81.22
Basic Earnings Per Share
84.62%
-0.14
-0.91 -0.89 -0.59 -0.59
Diluted Earnings Per Share
84.62%
-0.14
-0.91 -0.89 -0.59 -0.59
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Capitalizzazione:     |  Volume (24 ore):